GlassScriptPhysician profile
Mary A Washington
NPI 1811992894
$1,300.32
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $165 · 2021: $207 · 2022: $573 · 2023: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $251.57 | 2021-2022 | |
| Vifor Pharma, INC. | $179.36 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $152.82 | 2021-2023 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $109.89 | 2019-2023 | Jynarque |
| Akebia Therapeutics INC | $105.10 | 2019-2023 | Auryxia |
| Bayer Healthcare Pharmaceuticals INC. | $89.37 | 2022-2023 | |
| Mallinckrodt Enterprises LLC | $88.52 | 2019 | |
| Opko Pharmaceuticals, LLC | $79.89 | 2019-2023 | Rayaldee |
| Amgen INC. | $70.31 | 2019-2023 | Tavneos |
| Fresenius USA Marketing, INC. | $35.22 | 2020 | |
| Calliditas Therapeutics US INC. | $22.74 | 2022 | |
| Lilly USA, LLC | $22.34 | 2023 | Mounjaro |
| Glaxosmithkline, LLC. | $20.83 | 2022 | |
| Boston Scientific Corporation | $20.49 | 2020 | |
| Alexion Pharmaceuticals, INC. | $18.62 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $17.19 | 2022 | |
| Mallinckrodt Hospital Products INC. | $16.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Washington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.